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Background: Hyperglycaemic load has been shown to cause endothelial dysfunction in patients diagnosed with
diabetes mellitus or the pre-diabetic state of glucose intolerance. In the non-disease state such as in healthy
subjects, the effect of glucose loading is still uncertain with conflicting results. The aim of this study was to test the
hypothesis that an oral 75 g glucose load will not adversely attenuate the endothelial function of healthy
participants, 2 hours postprandial.
Methods: This is a prospective single arm study evaluating the brachial artery flow-mediated vasodilation of 12
healthy participants before and after a 75 g glucose loading. Participants’ age, body mass index, family history of
diabetes, fasting blood glucose and 2 hour postprandial glucose levels were recorded. All data were analysed with
SPSS 17.0 using Wilcoxon test.
Results: Primary analysis of the participants’ brachial artery flow mediated vasodilation before and 2 hours after
75 g oral glucose loading did not show any statistically significant attenuation (p > 0.05) in brachial artery
flow-mediated vasodilation, although a trend for reduction in endothelial relaxation was observed. Subgroup
analysis of healthy participants with a positive family history of diabetes confirmed a statistically significant
attenuation (p < 0.05) in brachial artery flow-mediated vasodilation after acute glucose loading even though the 2
hour postprandial blood glucose level, with a median value of 4.6 ± 2.2 mmol/L was within normal limits. This was
not observed in the group without a positive family history of diabetes.
Conclusion: Acute oral glucose loading significantly attenuates endothelial relaxation in healthy subjects with
positive family history of diabetes but showed no effect in those without a positive family history of diabetes. The
attenuation in endothelial relaxation was observed in the presence of normal glucose metabolism, suggesting a
defect in endothelium relaxation even in the non-disease state in the group predisposed to diabetes.
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Endothelial dysfunction is recognised as an early patho-
logical process in the natural history of atherosclerosis,
leading to long-term risk of cardiovascular events [1-3].
Postprandial hyperglycaemia, which is an independent
risk factor for cardiovascular disease, is also accompan-
ied by endothelial dysfunction [4,5]. It has been shown
that due to chronic hyperglycaemia, there is endothelial* Correspondence: chong_chee_fui@hotmail.com
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reproduction in any medium, provided the ordysfunction in individuals with insulin resistant, Type 2
diabetes mellitus [6-8], as well as in the pre-diabetic
stage which includes both impaired fasting glucose and
impaired glucose tolerance stage [8,9].
Endothelial dysfunction in these groups of individuals
is already well established by the time they present for
medical attention. Such endothelial dysfunction does not
occur suddenly but is a process that gradually develops
over time and may already be present even when the indi-
vidual was healthy and disease free. The effect of glucose
load on the endothelial function in healthy individuals has
previously been studied but the available data have beentd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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caemic load attenuates endothelial function while more
recent studies reported an absence of attenuation of endo-
thelium function [9-16].
To better address with the pathological consequences
of endothelial dysfunction, it is important that we under-
stand what happens in the pre-disease state. Therefore,
the purpose of this study was to test the hypothesis that
transient acute glucose loading, induced by a 75 g oral
glucose loading does not attenuate endothelial function
in healthy individuals.
Methods
This is a prospective single arm study assessing the effect of
a 75 g oral glucose load on vascular endothelial function
as measured by brachial artery flow-mediated vasodilation
[BAFMD]), in healthy individuals recruited from the Raja
Isteri Pengiran Anak Saleha (RIPAS) Hospital and from
Universiti Brunei Darussalam (UBD). Twelve healthy
participants between the ages of 18 and 30 were recruited
for this study. Those with type 1 or type 2 diabetes melli-
tus or any known past medical history of cardiovascular
diseases were excluded. Ethical approval to carry out this
study was granted by the Medical and Health Research and
Ethics Committee.
Participants were approached and briefed about the
study and given a “Participant Information Sheet”. Upon
agreement to participate, they were asked to sign the
consent form provided. Demographic data such as age,
gender, race, height, weight, medical history, and family
history of diabetes mellitus, medications and any allergies
were recorded. All data obtained during the BAFMD
procedure were recorded in Microsoft Excel spreadsheet
(Microsoft ®, USA) for data analysis.
Participants were instructed to fast from midnight and
to withhold any agents that could affect vasoreactivity
prior to the morning of the assessment [17]. These
agents included analgesics, caffeine and non-steroidal
anti-inflammatory medications [17]. Participants were
also asked to rest well the night before, as it has been
shown that stress has a negative effect on BAFMD [18,19].
For each participant, the BAFMD procedure was done
twice. On the morning of the study, participants were taken
to a quiet room with a constant ambient room temperature
of 22°C and allowed to rest for 10–15 minutes prior to
obtaining a blood specimen for fasting blood glucose level
and then undergoing the baseline BAFMD. Following this,
they were given an oral beverage containing 75 g of glucose
(Trutol ®75 Glucose Tolerance Beverage, Thermo Scientific
Inc. USA) and allowed to rest for two hours. After two
hours, another blood specimen was taken for the 2 hour
postprandial glucose level and the BAFMD procedure was
then repeated. All blood specimens were analysed by the
Biochemistry Laboratory at RIPAS hospital.Brachial artery flow mediated dilation (BAFMD)
This is a non-invasive technique used to assess endothelial
function as described by Corretti et al. [17]. Participants
were placed comfortably in a supine position with their left
arm fully extended and cradled in a silicon-filled mould
to prevent movement during the study. The ambient
temperature of the room was kept at a constant of 22°C.
The tourniquet pressure cuff (Torniquet 2500 ELC, VBM
Medizintechnik,Germany) was placed 5-10 cm above
the antecubital fossa of the left arm. A blood pressure
cuff was placed on the right upper arm to monitor blood
pressure before and after the procedure. An oxygen sat-
uration probe was attached to the right thumb of the
participant to monitor oxygen saturation and heart rate
(Ultraview, Spacelabs Medical, U.S.A.).
The brachial artery was first palpated and then visualised
using a B-mode ultrasound transducer (S-Nerve/VascularTM
Ultrasound Scan, Sonosite Inc., U.S.A.). Once visualised, the
position obtained by the transducer was marked. The best
possible segment of the brachial artery was obtained and
then the image was frozen at systole; indicated by maximum
dilation of the artery. Using the caliper system in the ultra-
sound, the diameter of the brachial artery was measured. At
least three readings were obtained along the artery and then
the values averaged.
An initial baseline diameter of the brachial artery was
measured (Do). Forearm ischaemia was achieved by inflat-
ing the tourniquet to a pressure of about 50-60 mmHg
above the systolic blood pressure to occlude blood flow
for 5 minutes. After 5 minutes, the cuff was deflated. The
artery was again visualised and the image frozen at 1 minute
(D1), 2 minutes (D2), 3 minutes (D3) and 5 minutes (D5)
to measure the diameter at the respective times.
BAFMD was calculated as the percentage change of
brachial artery diameter after cuff deflation relative to
the baseline measurement:
BAFMD = [(DX-DO)/DO] × 100, where DX is D1, D2,
D3 and D5 [17].
Statistical analysis
The study sample size was calculated based on the alter-
native hypothesis that a 75 g glucose loading will signifi-
cantly attenuate vascular endothelial vasodilatation. Based
on this with a study power of 80% and an alpha value set
at 0.05, to detect an expected difference in BAFMD of
2.8% (mean baseline BAFMD of 6.5% and a mean BAFMD
of 3.7% two hours after a 75 g glucose loading), the sample
size calculated was 5 [10]. However, in order to provide
a sample size large enough to confirm our null hypothesis,
a sample size of 12 was chosen.
All data collected were entered and analysed using
SPSS 17.0 (SPSS Inc., California). The percentage change
in BAFMD for each participant before and after the 75 g
glucose load was analysed using the Wilcoxon test. A
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BAFMD in participants with a family history of diabetes
and in those without a family history of diabetes. Ana-
lysis was only carried out on 11 participants; one was
excluded because the 2 hour blood glucose result could
not be obtained due to difficulty in getting the blood
sample (due to very fine veins). Statistical significance
was set at a p value < 0.05.
Results
Sociodemographic characteristics
Table 1 summarizes the sociodemographic characteristics
of all 11 participants. The participants’ ages ranged from 21
to 28 years, with a male to female ratio of 8:3. Participants
did not have any known medical conditions and were not
on any medications at the time of the study. Six participants
had a positive family history of diabetes. Of these six
participants, two of them had a first-degree relative
with diabetes while the remainder had both first and
second-degree relatives with diabetes. All participants
had normal fasting and 2 hour postprandial blood glucose
levels. [Normal fasting glucose: 3.5-6.0 mmol/L, 2 hour
postprandial blood glucose < 7.8 mmol/L].
Percentage change of BAFMD from baseline before and
after glucose load
Table 2 shows the overall analysis of BAFMD of the 11
participants. Although there was a trend towards reduced
BAFMD 2 hour after glucose loading (maximum percent-
age change of BAFMD from baseline was 5% reduction),
there was no statistical significance at all time intervals
(p value at 1 minute, 2 minutes, 3 minutes and 5 minutes
were all greater than 0.05; Figure 1). This confirms the
hypothesis of the present study that endothelial functionTable 1 Sociodemographic characteristics of participants acco









BMI (kg/m2) 20.8 (3.9)
Oral glucose tolerance test
Fasting blood glucose 4.5 (0.8)
2-hr postprandial blood glucose 4.4 (2.4)a
aSkewed to the right.
bSkewed to the left.
FHx = Family history.before and after the 75 g glucose load is not significantly
attenuated.
Percentage change of BAFMD from baseline in participants
with family history of diabetes
Figures 2 and 3 summarize the recorded percentage
change in BAFMD in participants with and without family
history of diabetes respectively. Participants with a positive
family history of diabetes showed significant reduction
in the 2 hour postprandial BAFMD at all time intervals
(p < 0.05 for 1 minute, 2 minutes, 3 minutes and 5 minutes;
maximum percentage change of BAFMD from baseline
was up 5.4% reduction; Figure 2). However, partici-
pants without a family history of diabetes did not
show any statistically significant change in endothelial
function after the glucose load (p > 0.05; maximum
percentage change of BAFMD from baseline was up to
4.5% increase; Figure 3).
Changes in heart rate and blood pressure before and
after the 75 g glucose load
Table 3 shows no statistically significant changes in either
heart rate (p = 0.8) or blood pressure (Systolic, p = 0.3;
Diastolic, p = 0.7) during the study period.
Discussion
The findings from our primary analysis support the hypoth-
esis that endothelium-dependent vasodilation is not signifi-
cantly affected by an oral glucose load in healthy individuals
with normal glucose metabolism, concurring with more
recent publications [15,16]. The difference between
this study and earlier studies that do show attenuation in
endothelial function after a glucose load may be due to
differences in the method of glucose delivery [12,20,21].rding to negative family history of diabetes (n = 5) and
of diabetes Positive FHx of diabetes
Frequency (%) Median (IQR) Frequency (%)
21.5 (4.0)b
3 (60.0) 5 (83.3)
2 (40.0) 1 (16.7)
4 (80.0) 1 (16.7)
0 (0.0) 3 (50.0)




Table 2 BAFMD values and its changes in participants before and after 75 g glucose load (n = 11)
Variable Median (IQR) Z Statisticsα p valueα
Before 75 g glucose load After 75 g glucose load
BAFMD, 1 min after cuff deflation (%) 12.3 (4.6) 11.2 (16.1) −1.245 0.213
BAFMD, 2 min after cuff deflation (%) 14.3 (12.2) 10.8 (9.6) −1.557 0.120
BAFMD, 3 min after cuff deflation (%) 14.0 (12.6) 10.0 (7.3) −1.778 0.075
BAFMD, 5 min after cuff deflation (%) 7.7 (8.9) 2.7 (10.7) −1.274 0.203
Baseline BAFMD (cm) – before oral glucose = 0.36 (0.13), after oral glucose = 0.35 (0.14).
αWilcoxon test.
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was used. Using this method, a dextrose solution was
directly infused through a catheter into the brachial
artery to be studied, in order to achieve a state of
hyperglycemia [12,20,21]. The method used in all other
studies involves giving an oral glucose load without
mentioning whether a state of hyperglycemia was achieved
[10,11,13-16]. The presence of an intravenous catheter may
directly affect vascular endothelial function, hence may be
a source of error.
Another potential issue is the different concentrations
of glucose that were used in various studies. The optimum
glucose concentration that would elicit a maximal change
in FMD is not certain. Different concentrations may play
an important role in determining endothelial function.
Hormonal variables, which could alter the physiology
of the endothelium, were also controlled in some of these
studies [16,21]. This included growth hormone, as well
as pancreatic hormones such as glucagon and insulin.
Both growth hormone and glucagon suppress the action
of insulin and thus could influence endothelium dependentFigure 1 BAFMD of participants before and after 75 g glucose load. L
showing a non-significant divergent trend at 2nd, 3rd and 5th minute of repevasodilation. Reed et al., for example, administered
somatostatin to their participants to suppress insulin
and growth hormone [16]. Synthetic forms of these
hormones were then replaced, thus ensuring constant
levels throughout their study. In our study, we have
not controlled these hormones but rather have allowed
for normal physiological processes of glucose absorption
and metabolism to occur.
Interestingly, our secondary subgroup analysis of the
data from participants with a positive family history of
diabetes showed a significant reduction in BAFMD at all
time point, 2 hours post glucose loading, even though
plasma glucose concentrations were within normal limits.
This significant reduction may explain the divergent trend
seen in the primary analysis in Figure 1. In the group with-
out a positive family history of diabetes, baseline readings
for BAFMD were almost parallel to those measured 2
hours after glucose loading, clearly indicating no effect
of glucose loading in healthy subjects. None of the 11
participants recruited had any underlying medical condi-
tions. They did not have any common risk factors associatedegend: BAFMD of participants before and after 75 g glucose load (n = 11)
rfusion.
Figure 2 BAFMD results of participants with family history of diabetes. Legend: BAFMD results of participants with family history of
diabetes (n = 6) showing significant reduction of BAFMD at all time intervals from 1 to 5 minutes of reperfusion 2 hour post prandial after
oral glucose loading.
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sion or hypercholesterolaemia, that could have accounted
for the differences observed between the groups of partici-
pants with and without a family history of diabetes. It is
noted that the group with positive family history of diabetes
had a slightly higher BMI than the group without a positive
family history of diabetes. This may suggest that the former
group may have some predisposition to metabolic disorders,
which could account for the significant changes seen.Figure 3 BAFMD results of participants without family history of diab
diabetes (n = 5) showing no significant changes in BAFMD 2 hour post praHowever, a separate subgroup analysis based on BMI >23
compared with those with BMI <23 did not showed any
statistically significant changes in BAFMD. This did not
support an assumption that higher BMI could have
accounted for the significant changes in BAFMD seen in
the group with a positive family history of diabetes and
added further support to our assumption that it is the fam-
ily history of diabetes that may be the determining factor.
Changes in blood pressure and heart rate during the studyetes. Legend: BAFMD results of participants without family history of
ndial after oral glucose loading.
Table 3 Changes in heart rate and blood pressure before
and after the 75 g glucose load





Heart rate 66 (10) 67 (12) −0.178 0.859
Blood pressure -
Systolic
113 (13) 113 (18) −0.979 0.327
Blood pressure -
Diastolic
72 (6) 73 (13) −0.312 0.755
αWilcoxon test.
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study group, there was no statistically significant change
in both heart rate and blood pressure before and after
the glucose load.
None of the earlier studies reporting attenuation of
endothelial function with glucose loading or hypergly-
cemia in their healthy subjects have reported this asso-
ciation of family history of diabetes with endothelial
dysfunction in response to glucose loading or hypergly-
cemia [10-14,20,21]. A study in 2006 by Goldfine et al.
was the only other study to report similar attenuation of
endothelial function in healthy subjects with positive
family history of diabetes when exposed to glucose loading
which lends further support to our assumption [21]. This
failure to associate positive family history of diabetes with
endothelial dysfunction in earlier studies (pre 2006) may
also perhaps contribute to the conflicting results reported
in literature. In the Goldfine study, endothelial dysfunction
was reported in the presence of hyperglycaemia after
glucose loading. This differs from our study in that,
endothelial dysfunction occurred in the presence of
normal post-prandial plasma glucose level, implying
normal glucose metabolism.
Beckman et al. suggested that attenuation of endothelial
function by hyperglycemia in normal healthy subject
occurs in part, via protein kinase C-beta activation,
which reduces endothelium derived nitric oxide synthesis
[20]. Our findings of reduced endothelial relaxation in the
presence of normal plasma glucose after acute glucose
loading, may suggest that this pathway of protein kinase
C-beta activation may already be present in healthy par-
ticipants with a positive family history of diabetes even
though they themselves have not developed signs and
symptoms of abnormal glucose metabolism. Follow-up
of these healthy participants with endothelial dysfunc-
tion should be done to see if they develop diabetes or
even cardiovascular disease in the long-term. If con-
firmed, this study could help in identifying those people
that may benefit from early lifestyle modifications including
avoiding sudden, rapid glucose load like consuming carbon-
ated drinks (soda) or sweets in excess, blood pressure andlipid control, weight management and smoking cessation to
reduce their risk.
Because of the small sample size, we were unable to
perform a subgroup analysis to compare the BAFMD in
participants according to gender, age or race (Table 1).
In addition this study was not designed to evaluate other
factors that may contribute to endothelium-dependent
flow mediated vasodilation such as hormones, dietary
habits, environmental influences or exercise patterns.
Future studies should consider a larger sample size for
each of these factors to assess their significance.
Conclusion
In healthy individuals with normal glucose metabolism
and no family history of diabetes, oral glucose loading does
not attenuate endothelial function. However, in healthy in-
dividuals with a family history of diabetes, despite normal
glucose metabolism, endothelial function appears to be at-
tenuated when exposed to an acute oral glucose load. Early
intervention in this group of individuals may be beneficial
in reducing their risk of developing diabetes and cardiovas-
cular morbidity and mortality in the long-term.
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